These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35335943)

  • 21. Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports.
    Enyeji AM; Arora A; Mangat HS
    Viral Immunol; 2024 Aug; 37(6):298-307. PubMed ID: 39096169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
    Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
    BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19.
    Smith DP; Oechsle O; Rawling MJ; Savory E; Lacoste AMB; Richardson PJ
    Front Pharmacol; 2021; 12():709856. PubMed ID: 34393789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SperoPredictor: An Integrated Machine Learning and Molecular Docking-Based Drug Repurposing Framework With Use Case of COVID-19.
    Ahmed F; Lee JW; Samantasinghar A; Kim YS; Kim KH; Kang IS; Memon FH; Lim JH; Choi KH
    Front Public Health; 2022; 10():902123. PubMed ID: 35784208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing.
    Fidan O; Mujwar S; Kciuk M
    Mol Divers; 2023 Feb; 27(1):463-475. PubMed ID: 35507211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Hybrid Protocol for Identifying Comorbidity-Based Potential Drugs for COVID-19 Using Biomedical Literature Mining, Network Analysis, and Deep Learning.
    Prabahar A; Palanisamy A
    Methods Mol Biol; 2022; 2496():203-219. PubMed ID: 35713866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing.
    Wu Y; Warner JL; Wang L; Jiang M; Xu J; Chen Q; Nian H; Dai Q; Du X; Yang P; Denny JC; Liu H; Xu H
    JCO Clin Cancer Inform; 2019 May; 3():1-9. PubMed ID: 31141421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point.
    Rogosnitzky M; Berkowitz E; Jadad AR
    JMIR Public Health Surveill; 2020 May; 6(2):e19199. PubMed ID: 32374264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combating COVID-19: The role of drug repurposing and medicinal plants.
    Khan SA; Al-Balushi K
    J Infect Public Health; 2021 Apr; 14(4):495-503. PubMed ID: 33743371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementia.
    Sikirzhytskaya A; Tyagin I; Sutton SS; Wyatt MD; Safro I; Shtutman M
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug repurposing against coronavirus disease 2019 (COVID-19): A review.
    Luo L; Qiu Q; Huang F; Liu K; Lan Y; Li X; Huang Y; Cui L; Luo H
    J Pharm Anal; 2021 Dec; 11(6):683-690. PubMed ID: 34513115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 challenges and its therapeutics.
    Rehman SU; Rehman SU; Yoo HH
    Biomed Pharmacother; 2021 Oct; 142():112015. PubMed ID: 34388532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview.
    Al-Karmalawy AA; Soltane R; Abo Elmaaty A; Tantawy MA; Antar SA; Yahya G; Chrouda A; Pashameah RA; Mustafa M; Abu Mraheil M; Mostafa A
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2.
    Ku KB; Shin HJ; Kim HS; Kim BT; Kim SJ; Kim C
    J Microbiol Biotechnol; 2020 Dec; 30(12):1843-1853. PubMed ID: 33203821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
    Sahoo BM; Ravi Kumar BVV; Sruti J; Mahapatra MK; Banik BK; Borah P
    Front Mol Biosci; 2021; 8():628144. PubMed ID: 33718434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19.
    Norinder U; Tuck A; Norgren K; Munic Kos V
    Biomed Pharmacother; 2020 Oct; 130():110582. PubMed ID: 32763818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.